Speeding Clinical Trials with BIOVIA Pipeline Pilot

Automating and Standardizing Clinical Trial Data Management for Neurodegenerative Diseases

One of the key challenges in developing treatments for neurodegenerative diseases lie in demonstrating their efficacy in clinical trials: many rely on empirical data, showcasing improvement in the ability of the patient to perform a qualitative task such as memory retention. As a result, many organizations have struggled with their ability to effectively standardize this data for submission; even collating data from different clinics in the same trial has proven difficult. This case study highlights how one pharma company utilized BIOVIA Pipeline Pilot to standardize data collection and analysis for their clinical trials for neurodegenerative diseases, improving their ability to process results and get sorely needed treatments to patients faster.